A major discovery in cancer research is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This crucial tumor inhibitor protein is frequently disabled in various kinds of malignancies, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research